Conigliari Matthew F MD is categorized under Neurologists in Morristown, NJ and active since 1981.
Conigliari Matthew F MD was established in 1981, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Neurologists business, which does work in the B2C market, and is classified as a Neurologists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Matthew Conigliari at the company’s single location by writing to 310 Madison Avenue # 120, Morristown, New Jersey NJ 07960 or by phoning (973) 285-1446. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Conigliari Matthew F MD |
| Contact Person: | Matthew Conigliari |
| Address: | 310 Madison Avenue # 120, Morristown, New Jersey 07960 |
| Phone Number: | (973) 285-1446 |
| Website Address: | neurosciencecenternj.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1981 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Neurologists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Conigliari Matthew F MD was started in 1981 to provide professional Neurologists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Matthew Conigliari for inquiries that concern Conigliari Matthew F MD by calling the company number (973) 285-1446, as your correspondence is most welcome. Additionally, the physical location of the single location of Conigliari Matthew F MD can be found at the coordinates 40.782176,-74.450368 as well as the street address 310 Madison Avenue # 120 in Morristown, New Jersey 07960.
For its online presence, you may visit Conigliari Matthew F MD’s website at neurosciencecenternj.com and engage with its social media outlets through on Twitter and on Facebook.